Hyperpyrexia in a patient with a left ventricular assist device: a diagnosis beyond the obvious.

As the number of patients receiving a left ventricular assist device increases, physicians must always keep in mind that several conditions can present with non-specific symptoms, such as fever, tachypnoea and confusion. We herein report the case of a left ventricular assist device patient who developed a life-threatening condition with acute hyperthermia, confusion and extremities' clonus and muscle spasms. The patient was diagnosed with serotonin syndrome, attributed to the coadministration of 2 commonly prescribed medications (citalopram and omeprazole). This case highlights that a significant proportion of left ventricular assist device patients is treated with serotonergic agents that may predispose them to the appearance of serotonin syndrome, a potentially life-threatening condition.

[1]  R. Starling,et al.  Frequency of depression and anxiety before and after insertion of a continuous flow left ventricular assist device. , 2014, The American journal of cardiology.

[2]  Robert L Kormos,et al.  Sixth INTERMACS annual report: a 10,000-patient database. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  V. Topkara,et al.  Left ventricular assist device-related infections: past, present and future , 2011, Expert review of medical devices.

[4]  E. Boyer,et al.  The serotonin syndrome. , 2005, The New England journal of medicine.